Clinical Associate Professor of Internal Medicine
[email protected]
Available to mentor
Shijing Jia, MD
Clinical Associate Professor
-
Jia S. 2024 Sep 2;PresentationIron Deficiency in Cystic Fibrosis: Observations of the Clinical Landscape
-
Jia S, Wang Y, Ross MH, Zuckerman JB, Murray S, Han MK, Cahalan SE, Lenhan BE, Best RN, Taylor-Cousar JL, Simon RH, Fitzgerald LJ, Troost JP, Sood SL, Gifford AH. J Cyst Fibros, 2024 Sep; 23 (5): 878 - 884.Journal ArticleAssociation between CFTR modulators and changes in iron deficiency markers in cystic fibrosis.
DOI:10.1016/j.jcf.2024.03.002 PMID: 38490920 -
Ware LB, Files DC, Fowler A, Aboodi MS, Aggarwal NR, Brower RG, Chang SY, Douglas IS, Fields S, Foulkes AS, Ginde AA, Harris ES, Hendey GW, Hite RD, Huang W, Lai P, Liu KD, Thompson BT, Matthay MA, National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network . JAMA, 2024 Aug 6; 332 (5): 390 - 400.Journal ArticleAcetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
DOI:10.1001/jama.2024.8772 PMID: 38762798 -
Ross MH, Jia S. ERJ Open Res, 2024 Jul; 10 (4):Journal ArticleHeterogeneity in non-cystic fibrosis bronchiectasis: insights from ASPEN trial participants.
DOI:10.1183/23120541.00372-2024 PMID: 39081500 -
Aggarwal NR, Nordwall J, Braun DL, Chung L, Coslet J, Der T, Eriobu N, Ginde AA, Hayanga AJ, Highbarger H, Holodniy M, Horcajada JP, Jain MK, Kim K, Laverdure S, Lundgren J, Natarajan V, Nguyen HH, Pett SL, Phillips A, Poulakou G, Price DA, Robinson P, Rogers AJ, Sandkovsky U, Shaw-Saliba K, Sturek JM, Trautner BW, Waters M, Reilly C, ACTIV-3/TICO Study Group . Clin Infect Dis, 2024 Jun 14; 78 (6): 1490 - 1503.Journal ArticleViral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
DOI:10.1093/cid/ciad780 PMID: 38376212 -
Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER, ACTIV-3/TICO Study Group . Lancet Microbe, 2024 Jun; 5 (6): e559 - e569.Journal ArticleEarly trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
DOI:10.1016/S2666-5247(24)00015-6 PMID: 38815595 -
Jia S. 2024 May 20;PresentationB92: CF in the Modulator Era: Where do we go from here?
-
Jensen TO, Grandits GA, Jain MK, Murray TA, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens RA, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER, ACTIV-3/TICO Study Group . J Infect Dis, 2024 Mar 14; 229 (3): 671 - 679.Journal ArticleEffect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
DOI:10.1093/infdis/jiad446 PMID: 37948759